Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.

Por Kavanaugh, A
Publicado em 1994

Lipid profiles in patients with rheumatoid arthritis

Por KAVANAUGH, A.
Publicado em 1998

Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis

Por Kavanaugh, A
Publicado em 2005

Health economics: implications for novel antirheumatic therapies

Por Kavanaugh, A
Publicado em 2005

A need for greater reporting of socioeconomic status and race in clinical trials

Por Lee, S, Kavanaugh, A
Publicado em 2004

Cigarette smoking, TB, and TNF inhibitors

Por Bieber, J, Kavanaugh, A
Publicado em 2003

Disparities in health according to socioeconomic status

Por Pincus, T, Lee, S, Kavanaugh, A
Publicado em 2005

Observational Studies on the Risk of Cancer Associated with TNF-Inhibitors in RA: A Review of their Methodologies and Results

Por Solomon, D. H., Mercer, E., Kavanaugh, A.
Publicado em 2012

Massive eosinophilic synovitis and reactive arthritis associated with filarial infection.

Por Kohem, C L, Kristiansen, S V, Kavanaugh, A F
Publicado em 1994

Do patients with older‐onset rheumatoid arthritis receive less aggressive treatment?

Por Tutuncu, Z, Reed, G, Kremer, J, Kavanaugh, A
Publicado em 2006

Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)

Por SCHULZE-KOOPS, H, LIPSKY, P E, KAVANAUGH, A F, DAVIS, L S
Publicado em 1996

OMERACT 7 psoriatic arthritis workshop: synopsis

Por Gladman, D, Strand, V, Mease, P, Antoni, C, Nash, P, Kavanaugh, A
Publicado em 2005

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with...

Por Kavanaugh, A, Gladman, D, van der Heijde, D, Purcaru, O, Mease, P
Publicado no Ann Rheum Dis (2015)

Recurrent Annular Peripheral Choroidal Detachment after Trabeculectomy

Por Liu, Shaohui, Sun, Lisa L., Kavanaugh, A. Scott, Langford, Marlyn P., Liang, Chanping
Publicado em 2013

Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate

Por Kavanaugh, A, Klareskog, L, van der Heijde, D, Li, J, Freundlich, B, Hooper, M
Publicado em 2008

Assessment of rituximab’s immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results

Por Kavanaugh, A, Rosengren, S, Lee, S J, Hammaker, D, Firestein, G S, Kalunian, K, Wei, N, Boyle, D L
Publicado em 2007

Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis

Por Huynh, D H, Boyd, T A, Etzel, C J, Cox, V, Kremer, J, Mease, P, Kavanaugh, A
Publicado no RMD Open (2017)

Health Care Utilization in Patients with Gout

Por Singh, Jasvinder A, Sarkin, A, Shieh, M, Khanna, D, Terkeltaub, R, Lee, SJ, Kavanaugh, A, Hirsch, JD
Publicado em 2010

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)

Por FURST, D, KEYSTONE, E, BREEDVELD, F, KALDEN, J, SMOLEN, J, ANTONI, C, BURMESTER, G, CROFFORD, L, KAVANAUGH, A
Publicado em 2001

Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis

Por Breedveld, F, Han, C, Bala, M, van der Heijde, D, Baker, D, Kavanaugh, A, Maini, R, Lipsky, P
Publicado em 2005